Flu News and Research

RSS

Long-lived plasma cells fail to establish after COVID mRNA vaccination, limiting long-term antibody response

Researchers found that SARS-CoV-2-specific plasma cells were largely excluded from the long-lived plasma cell compartment in the bone marrow after mRNA vaccination, explaining the short-lived antibody response.

2 Oct 2024

Macrophage memory following COVID infection provides cross-virus protection

More than 200 viruses can infect and cause disease in humans; most of us will be infected by several over the course of a lifetime.

30 Sep 2024

Health literacy gaps fuel unrealistic antibiotic expectations in primary care patients

Study reveals that over 93% of primary care patients expect antibiotics for common symptoms, especially in public clinics, with lack of education and health literacy contributing to these unrealistic expectations. Knowledge of antibiotic risks is a key factor influencing patient demand.

29 Sep 2024

Drug-free nasal spray demonstrates effectiveness in blocking viral and bacterial infections

Researchers from the Brigham detail how the spray they created may offer broad-spectrum protection from respiratory infections by COVID-19, influenza, everyday cold viruses, and pneumonia-causing bacteria

25 Sep 2024

H5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here?

Researchers reveal how H5N1 viruses rapidly adapted to mammals through genetic reassortment and specific mutations, raising concerns over potential pandemic risks. Evidence from mink, marine mammals, and dairy cattle shows mammal-to-mammal transmission.

25 Sep 2024

Novel nasal spray shows promise in preventing respiratory infections

New research published in Advanced Materials reports a novel nasal spray for preventing respiratory infections.

25 Sep 2024

Review highlights failures in global control strategies for bird flu transmission

A review of sustained mammal-to-mammal bird flu transmission in diverse species, led by The Pirbright Institute, shows global control strategies are not working.

24 Sep 2024

Nearly half of people older adults plan to get the updated COVID-19 vaccine, poll suggests

The newly updated COVID-19 vaccine just arrived in pharmacies and clinics nationwide, and a new poll suggests nearly half of people age 50 and older plan to get it.

23 Sep 2024

Florida’s new covid booster guidance is straight-up misinformation

In what has become a pattern of spreading vaccine misinformation, the Florida health department is telling older Floridians and others at highest risk from covid-19 to avoid most booster shots, saying they are potentially dangerous.

23 Sep 2024

U.S. health system underperforms despite massive spending, while Australia and the Netherlands excel

A recent Commonwealth Fund report compares health systems across 10 countries, revealing that the U.S. ranks last overall despite high healthcare spending, with significant gaps in health outcomes, equity, and access to care.

22 Sep 2024

Progress made in negotiations for global pandemic prevention agreement

Government-led negotiations on the world's first agreement to protect people from future pandemics made significant progress during the latest round of discussions that ended today at the World Health Organization (WHO).

20 Sep 2024

New research strengthens the case for a zoonotic origin of COVID-19

A new international collaborative study provides a list of the wildlife species present at the market from which SARS-CoV-2, the virus responsible for the COVID-19 pandemic, most likely arose in late 2019. The study is based on a new analysis of metatranscriptomic data released by the Chinese Center for Disease Control and Prevention (CDC).

20 Sep 2024

Seabirds' food-stealing behavior may facilitate spread of deadly avian flu

The deadly H5N1 avian influenza virus, which has killed millions of birds worldwide since 2021 – and in rare cases can be transmitted to humans – may be spread through the food-stealing behaviour of some seabirds.

16 Sep 2024

National survey reveals vaccine hesitancy ahead of flu and COVID-19 season

With flu season just around the corner and COVID-19 cases on the rise, a new nationwide survey from The Ohio State University Wexner Medical Center reveals hesitancy around vaccines this fall.

13 Sep 2024

Weight loss interventions may lower risk of severe infections in diabetics

Weight loss interventions could reduce the risk of severe cases of flu and other infections in people with diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) suggests.

9 Sep 2024

Arthritis medications could reverse COVID lung damage

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.

6 Sep 2024

Immune cells prevent the lungs' protective barrier from healing after viral infections

Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs' protective barrier from healing after viral infections like COVID-19.

4 Sep 2024

As interest from families wanes, pediatricians scale back on covid shots

When pediatrician Eric Ball opened a refrigerator full of childhood vaccines, all the expected shots were there — DTaP, polio, pneumococcal vaccine — except one.

4 Sep 2024

Seasonal patterns in Valley fever cases reveal climate-driven risks

Valley fever is an emerging fungal disease in the western United States that most often causes flu-like symptoms, but can also cause dangerous or even deadly complications. By analyzing data on reported cases of Valley fever in California, which have increased dramatically over the last two decades, researchers from the University of California San Diego and the University of California, Berkeley, have identified seasonal patterns that could help individuals and public health officials better prepare for future surges in Valley fever cases.

4 Sep 2024

Delayed antiviral treatment still beneficial for immunocompromised COVID-19 patients

Starting antiviral treatment as late as 14 days after infection with SARS-CoV-2 may still be beneficial in hosts with compromised immune systems, who are at greatest risk of developing severe COVID-19, according to researchers in the Center for Translational Antiviral Research at Georgia State University's Institute for Biomedical Sciences.

3 Sep 2024

Flu News and Research

Long-lived plasma cells fail to establish after COVID mRNA vaccination, limiting long-term antibody response

Macrophage memory following COVID infection provides cross-virus protection

Health literacy gaps fuel unrealistic antibiotic expectations in primary care patients

Drug-free nasal spray demonstrates effectiveness in blocking viral and bacterial infections

H5N1 bird flu is mutating fast and jumping to mammals - could the next pandemic be here?

Novel nasal spray shows promise in preventing respiratory infections

Review highlights failures in global control strategies for bird flu transmission

Nearly half of people older adults plan to get the updated COVID-19 vaccine, poll suggests

Florida’s new covid booster guidance is straight-up misinformation

U.S. health system underperforms despite massive spending, while Australia and the Netherlands excel

Progress made in negotiations for global pandemic prevention agreement

New research strengthens the case for a zoonotic origin of COVID-19

Seabirds' food-stealing behavior may facilitate spread of deadly avian flu

National survey reveals vaccine hesitancy ahead of flu and COVID-19 season

Weight loss interventions may lower risk of severe infections in diabetics

Arthritis medications could reverse COVID lung damage

Immune cells prevent the lungs' protective barrier from healing after viral infections

As interest from families wanes, pediatricians scale back on covid shots

Seasonal patterns in Valley fever cases reveal climate-driven risks

Delayed antiviral treatment still beneficial for immunocompromised COVID-19 patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News